BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29691470)

  • 1. CRISPR/Cas9 genome editing technology significantly accelerated herpes simplex virus research.
    Wang D; Wang XW; Peng XC; Xiang Y; Song SB; Wang YY; Chen L; Xin VW; Lyu YN; Ji J; Ma ZW; Li CB; Xin HW
    Cancer Gene Ther; 2018 Jun; 25(5-6):93-105. PubMed ID: 29691470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-mediated correction of human genetic disease.
    Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
    Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9: an advanced tool for editing plant genomes.
    Samanta MK; Dey A; Gayen S
    Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
    Meng X; Zhou H; Xu S
    Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.
    Vassena R; Heindryckx B; Peco R; Pennings G; Raya A; Sermon K; Veiga A
    Hum Reprod Update; 2016 Jun; 22(4):411-9. PubMed ID: 26932460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering herpes simplex viruses by infection-transfection methods including recombination site targeting by CRISPR/Cas9 nucleases.
    Russell TA; Stefanovic T; Tscharke DC
    J Virol Methods; 2015 Mar; 213():18-25. PubMed ID: 25479355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome.
    Ebrahimi S; Teimoori A; Khanbabaei H; Tabasi M
    Rev Med Virol; 2019 Jan; 29(1):e2009. PubMed ID: 30260068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections.
    Chen YC; Sheng J; Trang P; Liu F
    Viruses; 2018 May; 10(6):. PubMed ID: 29844277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering large viral DNA genomes using the CRISPR-Cas9 system.
    Suenaga T; Kohyama M; Hirayasu K; Arase H
    Microbiol Immunol; 2014 Sep; 58(9):513-22. PubMed ID: 25040500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
    Hong KQ; Liu DY; Chen T; Wang ZW
    World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-Based Genome Editing of HSV.
    Velusamy T; Gowripalan A; Tscharke DC
    Methods Mol Biol; 2020; 2060():169-183. PubMed ID: 31617178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
    Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
    Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temperature effect on CRISPR-Cas9 mediated genome editing.
    Xiang G; Zhang X; An C; Cheng C; Wang H
    J Genet Genomics; 2017 Apr; 44(4):199-205. PubMed ID: 28412228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-Cas9 technology and its application in haematological disorders.
    Zhang H; McCarty N
    Br J Haematol; 2016 Oct; 175(2):208-225. PubMed ID: 27619566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 17. [Research progress of CRISPR-Cas9 system for gene therapy].
    Zhan C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome editing in the mammalian brain using the CRISPR-Cas system.
    Nishiyama J
    Neurosci Res; 2019 Apr; 141():4-12. PubMed ID: 30076877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization analysis of CRISPR/Cas9 gene editing technology studies.
    Du QS; Cui J; Zhang CJ; He K
    J Zhejiang Univ Sci B; 2016 Oct.; 17(10):798-806. PubMed ID: 27704749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.